Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation

Neuropharmacology

Volumn 76, Issue PART A, 2014, Pages 118-126

  Proença, Mariana B ^a   Dombrowski, Patrícia A ^b   Da Cunha, Claudio ^b   Fischer, Luana ^a   Ferraz, Anete C ^a   Lima, Marcelo M S ^a  

^a Laboratório de Neurofisiologia   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Dopamine; Haloperidol; Parkinson's disease; Piribedil; REM sleep deprivation; Substantia nigra pars compacta

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE 2 RECEPTOR; HALOPERIDOL; HOMOVANILLIC ACID; PIRIBEDIL; PROTEIN C FOS;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DENSITY; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ACTIVITY; ENZYME ACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HORMONE METABOLISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEMORY; MENTAL PERFORMANCE; NEUROLOGIC EXAMINATION; NEUROTRANSMISSION; NONHUMAN; OBJECT RECOGNITION TEST; OPEN FIELD TEST; OXIDATION REDUCTION POTENTIAL; PARTICLE SIZE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POROSITY; PRIORITY JOURNAL; RAT; REM SLEEP DEPRIVATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; 5-HIAA; 5-HT; 5-HYDROXYINDOLEACETIC ACID; DA; DAT-KO; DHPG; DI; DIHYDROXYPHENYLGLYCOL; DISCRIMINATION INDEX; DOPAC; DOPAMINE; DOPAMINE TRANSPORTER KNOCKOUT; HALOPERIDOL; HOMOVANILLIC ACID; HVA; LATERODORSAL TEGMENTAL NUCLEI; LDT; MPTP; NA; NORADRENALINE; PARKINSON'S DISEASE; PD; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PIRIBEDIL; PPT; RAPID EYE MOVEMENT; REB; REBOUND; REM; REM SLEEP DEPRIVATION; REMSD; SEROTONIN; SNPC; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTAL AREA; VTA;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FUNCTIONAL NEUROIMAGING; HALOPERIDOL; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; NEURONS; PIRIBEDIL; RATS; RECEPTORS, DOPAMINE D2; RECOGNITION (PSYCHOLOGY); SEROTONIN; SLEEP DEPRIVATION; SUBSTANTIA NIGRA;

EID: 84886590334     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.08.024     Document Type: Article

References (38)

1. H. Almirall, V. Bautista, A. Sanchez-Bahillo, and M. Trinidad-Herrero Ultradian and circadian body temperature and activity rhythms in chronic MPTP treated monkeys Neurophysiol. Clin. 31 2001 161 170 (Pubitemid 32661118)
2. W. Asakura, K. Matsumoto, H. Ohta, and H. Watanabe Involvement of dopamine D2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test Pharmacol. Biochem. Behav. 48 1994 43 46
3. M.J. Bannon, E.B. Bunney, J.R. Zigun, L.R. Skirboll, and R.H. Roth Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol Naunyn Schmiedebergs Arch. Pharmacol. 312 1980 161 165 (Pubitemid 10123985)
4. P.L. Broadhurst Experiments in psychogenetics H.J. Einsenk, Experiments in Personality 1960 Routledge and Kegan Paul London 52 71
5. L. Dahan, B. Astier, N. Vautrelle, N. Urbain, B. Kocsis, and G. Chouvet Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep Neuropsychopharmacology 32 2007 1232 1241 (Pubitemid 46788854)
6. V.C. De Cock, M. Vidailhet, S. Leu, A. Texeira, E. Apartis, A. Elbaz, E. Roze, J.C. Willer, J.P. Derenne, Y. Agid, and I. Arnulf Restoration of normal motor control in Parkinson's disease during REM sleep Brain 130 2007 450 456 (Pubitemid 46181098)
7. T. Der-Ghazarian, S. Charntikov, F.A. Varela, C.A. Crawford, and S.A. McDougall Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats J. Neural Transm. 117 2010 573 583
8. E. Dere, M.A. Silva, and J.P. Huston Higher order memories for objects encountered in different spatio-temporal contexts in mice: evidence for episodic memory Rev. Neurosci. 15 2004 231 240 (Pubitemid 39388334)
9. K. Dzirasa, S. Ribeiro, R. Costa, L.M. Santos, S.C. Lin, A. Grosmark, T.D. Sotnikova, R.R. Gainetdinov, M.G. Caron, and M.A. Nicolelis Dopaminergic control of sleep-wake states J. Neurosci. 26 2006 10577 10589 (Pubitemid 44564610)
10. A. Ennaceur, and J. Delacour A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data Behav. Brain Res. 31 1988 47 59
11. A. Ennaceur, S. Michalikova, A. Bradford, and S. Ahmed Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks Behav. Brain Res. 159 2005 247 266 (Pubitemid 40462501)
12. A. Enz, F. Hefti, and W. Frick Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP Eur. J. Pharmacol. 101 1984 37 44 (Pubitemid 14117881)
13. R. Erro, G. Santangelo, M. Picillo, C. Vitale, M. Amboni, K. Longo, A. Costagliola, M.T. Pellecchia, R. Allocca, A. De Rosa, G. De Michele, L. Santoro, and P. Barone Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients J. Neurol. 259 2012 1808 1813
14. L.S. Forno, J.W. Langston, L.E. DeLanney, I. Irwin, and G.A. Ricaurte Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys Ann. Neurol. 20 1986 449 455 (Pubitemid 16005662)
15. A. Gobert, B. Di Cara, L. Cistarelli, and M.J. Millan Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors J. Pharmacol. Exp. Ther. 305 2003 338 346 (Pubitemid 36373869)
16. J.W. Langston, L.S. Forno, C.S. Rebert, and I. Irwin Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyrine (MPTP) in the squirrel monkey Brain Res. 292 1984 390 394 (Pubitemid 14190114)
17. I. Lena, S. Parrot, O. Deschaux, S. Muffat-Joly, V. Sauvinet, B. Renaud, M.F. Suaud-Chagny, and C. Gottesmann Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats J. Neurosci. Res. 81 2005 891 899 (Pubitemid 41532155)
18. M.M. Lima, M.L. Andersen, A.B. Reksidler, A.C. Ferraz, M.A. Vital, and S. Tufik Paradoxical sleep deprivation modulates tyrosine hydroxylase expression in the nigrostriatal pathway and attenuates motor deficits induced by dopaminergic depletion CNS Neurol. Disord. Drug Targets 11 2012 359 368
19. M.M.S. Lima, M.L. Andersen, A.B. Reksidler, M.A.B.F. Vital, and S. Tufik The role of the substantia nigra pars compacta in regulating sleep patterns in rats PLoS One 2 2007 e513
20. M.M.S. Lima Sleep disturbances in Parkinson's disease: the contribution of dopamine in REM sleep regulation Sleep Med. Rev. 17 5 2013 367 375
21. M.M.S. Lima, M.L. Andersen, A.B. Reksidler, A. Silva, A. Zager, S.M. Zanata, M.A. Vital, and S. Tufik Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation Behav. Brain Res. 188 2008 406 411
22. S.M. Luckman, R.E. Dyball, and G. Leng Induction of c-fos expression in hypothalamic magnocellular neurons requires synaptic activation and not simply increased spike activity J. Neurosci. 14 1994 4825 4830 (Pubitemid 24237904)
23. R.B. Machado, D.C. Hipolide, A.A. Benedito-Silva, and S. Tufik Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery Brain Res. 1004 2004 45 51 (Pubitemid 38368061)
24. K.J. Maloney, L. Mainville, and B.E. Jones c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery Eur. J. Neurosci. 15 2002 774 778 (Pubitemid 35471944)
25. M.J. Millan From the cell to the clinic: a comparative review of the partial D2/D3 receptor agonist and alpha2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease Pharmacol. Ther. 1258 2010 229 273
26. M.J. Millan, D. Cussac, G. Milligan, C. Carr, V. Audinot, A. Gobert, F. Lejeune, J.M. Rivet, M. Brocco, D. Duqueyroix, J.P. Nicolas, J.A. Boutin, and A. Newman-Tancredi Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization J. Pharmacol. Exp. Ther. 297 2001 876 887 (Pubitemid 32472482)
27. J.I. Morgan, and T. Curran Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun Annu. Rev. Neurosci. 14 1991 421 451
28. R.G. Morris Episodic-like memory in animals: psychological criteria, neural mechanisms and the value of episodic-like tasks to investigate animal models of neurodegenerative disease Philos. Trans. R Soc. Lond B Biol. Sci. 356 2001 1453 1465 (Pubitemid 32948870)
29. G.P. Nunes Jr., S. Tufik, and J.N. Nobrega Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation Brain Res. Bull 34 1994 453 456
30. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates fifth ed. 2005 Academic Press San Diego
31. E. Petroske, G.E. Meredith, S. Callen, S. Totterdell, and Y.S. Lau Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment Neuroscience 106 2001 589 601 (Pubitemid 32925247)
32. K. Pungor, M. Papp, K. Kekesi, and G. Juhasz A novel effect of MPTP: the selective suppression of paradoxical sleep in cats Brain Res. 525 1990 310 314 (Pubitemid 20257752)
33. A. Reches, H.R. Wagner, V. Jackson-Lewis, and S. Fahn Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade Brain Res. 347 1985 346 349 (Pubitemid 16213510)
34. A.B. Reksidler, M.M.S. Lima, P. Dombrowski, M.L. Andersen, S.M. Zanata, R. Andreatini, S. Tufik, and M.A.B.F. Vital Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease J. Neurosci. Methods 167 2008 268 277 (Pubitemid 350235638)
35. C.A. Santos, M.L. Andersen, M.M. Lima, and S. Tufik Gentle handling temporarily increases c-Fos in the substantia nigra pars compacta Braz. J. Med. Biol. Res. 41 2008 920 925
36. C. Souchay, M. Isingrini, and R. Gil Metamemory monitoring and Parkinson's disease J. Clin. Exp. Neuropsychol. 28 2006 618 630
37. S. Tufik Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation Psychopharmacology (Berl) 72 1981 257 260 (Pubitemid 11142971)
38. S. Tufik, C.J. Lindsey, and E.A. Carlini Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain? Pharmacology 16 1978 98 105 (Pubitemid 8230482)